Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Development Update

21st Jun 2013 07:00

RNS Number : 5381H
Omega Diagnostics Group PLC
21 June 2013
 



 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Allergy Development Update

 

Omega (AIM:ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has finalised the specific allergy assay protocol for use with the IDS-iSYS platform. Following a design review meeting by its Allergy Project Team, the protocol which is now fixed for the remainder of the development programme has effectively eliminated the previously reported imprecision issues.

 

The Company will now begin the final claim support work for the first 10 allergens that have already been optimised. As previously reported, sufficient patient serum samples are in stock to allow the optimisation work to begin with a further 30 allergens and the Company remains on track to launch with a panel of 40 tests by the end of the current financial year.

 

Commenting on the development update, Andrew Shepherd, Chief Executive, stated: "This is a crucial milestone in the development of our allergy assays on the IDS-iSYS platform. We now look forward to making further significant progress towards our projected launch date."

 

 

Contacts:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

finnCap Ltd

Tel: 020 7220 0500

Geoff Nash/Christopher Raggett (Corporate Finance)

Stephen Norcross/Mia Gardner (Corporate Broking)

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDLUBDBGXG

Related Shares:

ODX.L
FTSE 100 Latest
Value8,415.25
Change7.81